Literature DB >> 2891727

Identification of a new hereditary amyloidosis prealbumin variant, Tyr-77, and detection of the gene by DNA analysis.

M R Wallace1, F E Dwulet, E C Williams, P M Conneally, M D Benson.   

Abstract

In the last several years, five human plasma prealbumin (transthyretin) variants have been discovered in association with hereditary amyloidosis, a late-onset fatal disorder. We recently studied a patient of German descent with peripheral neuropathy and bowel dysfunction. Biopsied rectal tissue contained amyloid that stained with anti-human prealbumin. Amino acid sequence analysis of the patient's plasma prealbumin revealed both normal and variant prealbumin molecules, with the variant containing a tyrosine at position 77 instead of serine. We predicted a single nucleotide change in codon 77 of the variant prealbumin gene, which we then detected in the patient's DNA using the restriction enzyme SspI and a specifically tailored genomic prealbumin probe. DNA tests of other family members identified several gene carriers. This is the sixth prealbumin variant implicated in amyloidosis, and adds to the accumulating evidence that the prealbumin amyloidoses are more varied and prevalent than previously thought.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2891727      PMCID: PMC442492          DOI: 10.1172/JCI113293

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

Review 1.  Thyroxine transport proteins of plasma. Molecular properties and biosynthesis.

Authors:  J Robbins; S Y Cheng; M C Gershengorn; D Glinoer; H J Cahnmann; H Edelnoch
Journal:  Recent Prog Horm Res       Date:  1978

2.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

3.  Hereditary cerebral haemorrhage with amyloidosis.

Authors:  G Gudmundsson; J Hallgrímsson; T A Jónasson; O Bjarnason
Journal:  Brain       Date:  1972       Impact factor: 13.501

4.  Hereditary amyloidosis.

Authors:  C Andrade; S Araki; W D Block; A S Cohen; C E Jackson; Y Kuroiwa; J Nissim; E Sohar; V A McKusick; M W Van Allen
Journal:  Arthritis Rheum       Date:  1970 Nov-Dec

5.  Polymorphism of human plasma thyroxine binding prealbumin.

Authors:  F E Dwulet; M D Benson
Journal:  Biochem Biophys Res Commun       Date:  1983-07-29       Impact factor: 3.575

6.  Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A.

Authors:  C C Blake; M J Geisow; S J Oatley; B Rérat; C Rérat
Journal:  J Mol Biol       Date:  1978-05-25       Impact factor: 5.469

7.  Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate.

Authors:  R L Heinrikson; S C Meredith
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

8.  Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type).

Authors:  S Tawara; M Nakazato; K Kangawa; H Matsuo; S Araki
Journal:  Biochem Biophys Res Commun       Date:  1983-11-15       Impact factor: 3.575

9.  Prealbumin and retinol binding protein serum concentrations in the Indiana type hereditary amyloidosis.

Authors:  M D Benson; F E Dwulet
Journal:  Arthritis Rheum       Date:  1983-12

10.  Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy.

Authors:  P P Costa; A S Figueira; F R Bravo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

View more
  11 in total

1.  A DNA test for Indiana/Swiss hereditary amyloidosis (FAP II).

Authors:  M R Wallace; P M Conneally; M D Benson
Journal:  Am J Hum Genet       Date:  1988-08       Impact factor: 11.025

2.  Fibril in senile systemic amyloidosis is derived from normal transthyretin.

Authors:  P Westermark; K Sletten; B Johansson; G G Cornwell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

3.  Haplotype analysis of familial amyloidotic polyneuropathy. Evidence for multiple origins of the Val----Met mutation most common to the disease.

Authors:  K Yoshioka; H Furuya; H Sasaki; M J Saraiva; P P Costa; Y Sakaki
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

4.  Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis.

Authors:  K Higuchi; K Kitagawa; H Naiki; K Hanada; M Hosokawa; T Takeda
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

5.  Familial amyloidotic polyneuropathy: transthyretin (prealbumin) variants in kindreds of Italian origin.

Authors:  M J Saraiva; P P Costa; M do R Almeida; A Banzhoff; K Altland; A Ferlini; G Rubboli; R Plasmati; C A Tassinari; G Romeo
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

6.  A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology.

Authors:  D R Jacobson; P D Gorevic; J N Buxbaum
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

7.  Finnish type of familial amyloidosis: cosegregation of Asp187----Asn mutation of gelsolin with the disease in three large families.

Authors:  T Hiltunen; S Kiuru; V Hongell; T Heliö; J Palo; L Peltonen
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

Review 8.  Unifying features of systemic and cerebral amyloidosis.

Authors:  J Ghiso; T Wisniewski; B Frangione
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

9.  Haplotype analysis of French, British and other European patients with familial amyloid polyneuropathy (met 30 and tyr 77).

Authors:  M M Reilly; D Adams; M B Davis; G Said; A E Harding
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

10.  Transthyretin gene mutations in British and French patients with amyloid neuropathy.

Authors:  K Bhatia; M Reilly; D Adams; M B Davis; C H Hawkes; P K Thomas; G Said; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.